Literature DB >> 18415676

Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols.

Katia Aquilano1, Sara Baldelli, Giuseppe Rotilio, Maria Rosa Ciriolo.   

Abstract

Natural polyphenols can exert protective action on a number of pathological conditions including neurodegenerative disorders. The neuroprotective effects of many polyphenols rely on their ability to permeate brain barrier and here directly scavenge pathological concentration of reactive oxygen and nitrogen species and chelate transition metal ions. Importantly, polyphenols modulate neuroinflammation by inhibiting the expression of inflammatory genes and the level of intracellular antioxidants. Parkinson's disease (PD) is a neurodegenerative disorder characterized by several abnormalities including inflammation, mitochondrial dysfunction, iron accumulation and oxidative stress. There is considerable evidence showing that cellular oxidative damage occurring in PD might result also from the actions of altered production of nitric oxide (NO). Indeed, high levels of neuronal and inducible NO synthase (NOS) were found in substantia nigra of patients and animal models of PD. Here, we evaluate the involvement of NOS/NO in PD and explore the neuroprotective activity of natural polyphenol compounds in terms of anti-inflammatory and antioxidant action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18415676     DOI: 10.1007/s11064-008-9697-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  113 in total

1.  Effects of prenylated flavonoids and biflavonoids on lipopolysaccharide-induced nitric oxide production from the mouse macrophage cell line RAW 264.7.

Authors:  B S Cheon; Y H Kim; K S Son; H W Chang; S S Kang; H P Kim
Journal:  Planta Med       Date:  2000-10       Impact factor: 3.352

2.  Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

Authors:  Y He; S Appel; W Le
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

3.  Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration.

Authors:  B Cutillas; M Espejo; J Gil; I Ferrer; S Ambrosio
Journal:  Neuroreport       Date:  1999-08-20       Impact factor: 1.837

Review 4.  The roles of polyphenols in cancer chemoprevention.

Authors:  Ki Won Lee; Hyong Joo Lee
Journal:  Biofactors       Date:  2006       Impact factor: 6.113

5.  Effects of dietary tea catechins on alpha-tocopherol levels, lipid peroxidation, and erythrocyte deformability in rats fed on high palm oil and perilla oil diets.

Authors:  F Nanjo; M Honda; K Okushio; N Matsumoto; F Ishigaki; T Ishigami; Y Hara
Journal:  Biol Pharm Bull       Date:  1993-11       Impact factor: 2.233

6.  Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha.

Authors:  T L Wadsworth; T L McDonald; D R Koop
Journal:  Biochem Pharmacol       Date:  2001-10-01       Impact factor: 5.858

Review 7.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

Authors:  E Middleton; C Kandaswami; T C Theoharides
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

8.  Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity.

Authors:  Jun Chen; Christophe Wersinger; Anita Sidhu
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

9.  Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice.

Authors:  Malgorzata Chalimoniuk; Józef Langfort; Nadezda Lukacova; Józef Marsala
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

10.  Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism.

Authors:  A S Mandir; S Przedborski; V Jackson-Lewis; Z Q Wang; C M Simbulan-Rosenthal; M E Smulson; B E Hoffman; D B Guastella; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

View more
  65 in total

1.  Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.

Authors:  Zhen-tao Zhang; Xue-bing Cao; Nian Xiong; Hong-cai Wang; Jin-sha Huang; Sheng-gang Sun; Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

2.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

3.  Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo.

Authors:  Sang Keun Ha; Eunjung Moon; Pyeongjae Lee; Jong Hoon Ryu; Myung Sook Oh; Sun Yeou Kim
Journal:  Neurochem Res       Date:  2012-03-24       Impact factor: 3.996

4.  LPS induces mediators of neuroinflammation, cell proliferation, and GFAP expression in human astrocytoma cells U373MG: the anti-inflammatory and anti-proliferative effect of guggulipid.

Authors:  Rituraj Niranjan; Rajasekar Nagarajan; Kashif Hanif; Chandishwar Nath; Rakesh Shukla
Journal:  Neurol Sci       Date:  2013-09-07       Impact factor: 3.307

5.  Selective monocationic inhibitors of neuronal nitric oxide synthase. Binding mode insights from molecular dynamics simulations.

Authors:  He Huang; Haitao Ji; Huiying Li; Qing Jing; Kristin Jansen Labby; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2012-07-10       Impact factor: 15.419

6.  Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.

Authors:  Heng-Yen Wang; Yajuan Qin; Huiying Li; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2016-04-20       Impact factor: 7.446

7.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Harald Weninger; Christina Patrick; Anthony Adame; Radmila Santic; Stefanie Meindl; Benjamin Vigl; Oskar Smrzka; Achim Schneeberger; Frank Mattner; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-14       Impact factor: 17.088

8.  Structure-guided design of selective inhibitors of neuronal nitric oxide synthase.

Authors:  He Huang; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-28       Impact factor: 7.446

Review 9.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

Review 10.  Plant polyphenols as dietary antioxidants in human health and disease.

Authors:  Kanti Bhooshan Pandey; Syed Ibrahim Rizvi
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.